Cargando…

Systematic profiling of polyclonal HIV antibodies and prediction of effector functions

Detalles Bibliográficos
Autor principal:	Brown, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442064/ http://dx.doi.org/10.1186/1742-4690-9-S2-P86

Ejemplares similares

Developing a quantitative model of antibody effector function
por: Boesch, AW, et al.
Publicado: (2012)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2021)

Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2022)

Comprehensive mapping of SIVmac239 envelope antigenic determinants recognized by specific polyclonal antibodies in vaccinated and/or infected macaques
por: Guo, J, et al.
Publicado: (2012)

Role of functional avidity in HIV-specific memory CD8 T cell effector functions
por: Lemon, Tiffany, et al.
Publicado: (2012)

P205: An outbreak of polyclonal pseudomonas aeruginosa bacteremia in hemodialysis patients
por: Ciobotaro, P, et al.
Publicado: (2013)

Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.
por: Serafini, G, et al.
Publicado: (2012)

Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNFα polyclonal immune ovine Fab similar to D-CytoFab
por: Newham, P, et al.
Publicado: (2011)

AZD9773 is a novel and potent anti-TNFα polyclonal ovine immune Fab
por: Newham, P, et al.
Publicado: (2011)

Igm-enriched polyclonal immunoglobulins in an experimental model of gram negative pneumonia developing septic shock
por: Vaschetto, R, et al.
Publicado: (2015)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003)

Quantitative single-cell characterization of CAR+ T cell effector functions
por: Liadi, Ivan, et al.
Publicado: (2013)

Safety and tolerability of an ovine-derived polyclonal anti-TNFα Fab fragment (AZD9773) in patients with severe sepsis
por: Morris, P, et al.
Publicado: (2011)

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
por: Evans, MC, et al.
Publicado: (2012)

Monoclonal antibodies that recognize important functional elements of the HIV-1 integrase enzyme
por: Maroun, Richard G, et al.
Publicado: (2012)

Case study: biosimilar anti TNFalpha (Adalimumab) analysis of Fc effector functions
por: Lindemann, Carsten, et al.
Publicado: (2013)

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
por: Sholukh, AM, et al.
Publicado: (2012)

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
por: Janssen, Nicole, et al.
Publicado: (2015)

Investigation on antigangliosides antibodies in asymptomatic HIV patients
por: Nicolae, Ilinca, et al.
Publicado: (2014)

Fas expression in memory CD8+ T cell subsets augments cellular differentiation and effector function
por: Yamamoto, Tori, et al.
Publicado: (2015)

Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
por: Seung, E, et al.
Publicado: (2012)

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies
por: Czernekova, Lydie, et al.
Publicado: (2014)

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013)

P04-21. Different human serum antibody profiles elicited by three candidate HIV vaccines using different immunization approaches
por: Vaine, M, et al.
Publicado: (2009)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2014)

Feasibility of testing antibodies to HIV from filter paper using HIV rapid test kits
por: Ganesan, A, et al.
Publicado: (2010)

Changes in HIV transmission profile in Arad county
por: Negru, Dana, et al.
Publicado: (2014)

Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
por: Sharma, SK, et al.
Publicado: (2012)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients
por: Karita, E, et al.
Publicado: (2009)

Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection
por: Thobakgale, C, et al.
Publicado: (2012)

Antibody effector function is regulated by a combination of adaptive and innate signals
por: Mahan, A, et al.
Publicado: (2012)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
por: Bulatović, Maja, et al.
Publicado: (2011)

Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodies.
por: Gore, M. E., et al.
Publicado: (1983)

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection
por: Chen, W, et al.
Publicado: (2009)

Neutralization and enhancement of trans infection by erythrocyte-bound HIV with antibodies and complement
por: Beck, Z, et al.
Publicado: (2012)

Production of Erythropoietin-Specific Polyclonal Antibodies
por: Maboudi, Kourosh, et al.
Publicado: (2017)

Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sgsb0vc881b7cquqf2hg8s1f4f